Oral maxillary squamous carcinoma: an indication for neck dissection in the clinically negative neck
- PMID: 21990223
- DOI: 10.1002/hed.21631
Oral maxillary squamous carcinoma: an indication for neck dissection in the clinically negative neck
Abstract
Background: This multicenter study was undertaken to characterize the metastatic behavior of oral maxillary squamous carcinoma and to determine the role of selective neck dissection.
Methods: A retrospective, multicenter study of patients surgically treated for oral maxillary squamous carcinoma was completed. Data collected included primary tumor location, cervical lymph node status, and neck failure rate.
Results: The study included 146 patients. The adjusted regional metastatic rate was 31.4%. Of those N0 (clinically negative) necks treated with or without neck dissection, 14.4% developed cervical metastasis. Within the cohort, 7.5% of patients died with distant disease. The regional salvage rate was 52.9%. None of the patients with locoregional failures were salvaged.
Conclusions: Maxillary palatal, alveolar, and gingival squamous carcinomas exhibit aggressive regional metastatic behavior. Surgical salvage rates for neck failure are low; therefore, selective neck dissection (levels I-III) is recommended at the time of resection of T2, T3, and T4 maxillary squamous carcinomas.
Copyright © 2010 Wiley Periodicals, Inc.
Similar articles
-
Oral maxillary squamous cell carcinoma: management of the clinically negative neck.J Oral Maxillofac Surg. 2008 Apr;66(4):762-6. doi: 10.1016/j.joms.2007.12.017. J Oral Maxillofac Surg. 2008. PMID: 18355602 Review.
-
Management of the neck and regional recurrence in squamous cell carcinoma of the maxillary alveolus and hard palate compared with other sites in the oral cavity.Head Neck. 2013 Feb;35(2):265-9. doi: 10.1002/hed.22957. Epub 2012 Feb 6. Head Neck. 2013. PMID: 22308020
-
Neck recurrence after level I-IV or I-III selective neck dissection in the management of the clinically N0 neck in patients with oral squamous cell carcinoma.Head Neck. 2011 Mar;33(3):403-6. doi: 10.1002/hed.21466. Head Neck. 2011. PMID: 20629073
-
Efficacy of selective neck dissection for nodal metastasis with involvement of nonlymphatic structures.Head Neck. 2011 Aug;33(8):1099-105. doi: 10.1002/hed.21587. Epub 2010 Nov 10. Head Neck. 2011. PMID: 21755555
-
Transoral laser resection with staged discontinuous neck dissection for oral cavity and oropharynx squamous cell carcinoma.Laryngoscope. 1995 Jan;105(1):53-60. doi: 10.1288/00005537-199501000-00013. Laryngoscope. 1995. PMID: 7837914 Review.
Cited by
-
Guidelines for delineation of lymphatic clinical target volumes for high conformal radiotherapy: head and neck region.Radiat Oncol. 2011 Aug 19;6:97. doi: 10.1186/1748-717X-6-97. Radiat Oncol. 2011. PMID: 21854585 Free PMC article. Review.
-
Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline.J Clin Oncol. 2019 Jul 10;37(20):1753-1774. doi: 10.1200/JCO.18.01921. Epub 2019 Feb 27. J Clin Oncol. 2019. PMID: 30811281 Free PMC article.
-
Cancer of the gingiva.Eur Arch Otorhinolaryngol. 2016 Jun;273(6):1335-45. doi: 10.1007/s00405-015-3516-x. Epub 2015 Feb 4. Eur Arch Otorhinolaryngol. 2016. PMID: 25649283 Review.
-
Applicability of preoperative nuclear morphometry to evaluating risk for cervical lymph node metastasis in oral squamous cell carcinoma.PLoS One. 2014 Dec 30;9(12):e116452. doi: 10.1371/journal.pone.0116452. eCollection 2014. PLoS One. 2014. PMID: 25549090 Free PMC article.
-
Cervical metastases of squamous cell carcinoma of the maxilla: a retrospective study of 25 years.Clin Oral Investig. 2014 May;18(4):1221-1227. doi: 10.1007/s00784-013-1070-8. Epub 2013 Aug 11. Clin Oral Investig. 2014. PMID: 23934238
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical